A carregar...
Transcriptome Alterations in Liver Metastases of Colorectal Cancer After Acquired Resistance to Cetuximab
Background/Aim: Cetuximab in combination with chemotherapy is recommended as first-line therapy for metastatic colorectal cancer (mCRC) with wild-type RAS. However, drug resistance to cetuximab exists widely in mCRC and reduces the prognosis of patients. Although some genomic alterations have been d...
Na minha lista:
| Publicado no: | Cancer Genomics Proteomics |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
International Institute of Anticancer Research
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6542644/ https://ncbi.nlm.nih.gov/pubmed/31018951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/cgp.20126 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|